Analgesic and anti-inflammatory potential of Lupeol isolated from Indian traditional medicinal plant Crateva adansonii screened through in vivo and in silico approaches

Abstract

Background Lupeol, a triterpene bioactive compound isolated from Indian traditional plant Crateva adansonii acted as promising and alternative anti-inflammatory agent to treatments of diseases related to inflammation. The inflammatory process in the body serves an important function in the control and repair of injury. However, it is self-perpetuating in number of disease conditions, which must be prevented and treated. Worldwide most prescribing NASID drug shows severe side effects. Whereas drug from natural origin shows dual inhibition of inflammatory and analgesic target protein with more efficacy and less side effects than NSAID drugs. Our study aims to isolate and screen the analgesic and anti-inflammatory potential of lupeol, a pentacyclic triterpenoid isolated from leaf extract of Crateva adansonii belongs to Capparaceae family commonly used Indian traditional medicine for treating inflammatory diseases. Results Methanol and chloroform leaf extracts (ME and CE) and lupeol fraction (LF) of plant Crateva adansonii is investigated through employing in vivo male Wistar albino rat model. Acute toxicity study of C. adansonii ME and CE leaf extracts reveals that no mortality and no behavioral changes in experimental animals up to 2 g/kg. So no lethal dose we consider two optimal doses 200 and 400 mg of plant leaf extracts for in vivo inflammatory and analgesic study. In vivo acute and chronic anti-inflammatory activity was carried out through carrageenan-induced rat paw edema and cotton pellet-induced granuloma models. LF (100 mg/kg, oral route) of Crateva adansonii evoked highest percentage of inflammation inhibition (50 and 33.96% respectively) in both in vivo acute and chronic inflammation model among all tested samples (ME and CE 200 mg and 400 mg/kg, oral route) including reference standard (10 mg/kg, oral route) indomethacin. Carrageenan-challenged experimental animals were screened for one inflammatory marker enzyme myeloperoxidase (MPO), inflammatory products such as Prostaglandrin E2 (PGE2), and eight different cytokines markers (TNFα, IL-6, IFN γ, IL-1α, IL-1β, MCP-1, Rantes, and MIP) associated with inflammation reveals that LF (100 mg/kg, oral route) of Crateva adansonii shows prominent anti-inflammatory activity than reference standard indomethacin (10 mg/kg, oral route) over all these biological tested parameters. In vivo analgesic assays such as hot plate assay and acetic acid-induced writhing assay revealed that LF (100 mg/kg, oral route) possesses significant analgesic activity (11.60 s and 69.05%) when compared with standard drug pentazocine(10 mg/kg, oral route). Finally, we made an in silico screening of lupeol against analgesic (nAChR) and anti-inflammatory (COX-2) target proteins reveals that lupeol possess highest binding affinity with nAChR and COX-2 target proteins (− 8.5 and − 9.0 Kcal/mol) over the reference standard pentazocine and indomethacin (− 7.0 and − 8.4 Kcal/mol) respectively. Conclusion The present study result provides a pharmacological evidences for analgesic and anti-inflammatory potential of lupeol isolated from Indian traditional plant Crateva adansonii act as a multi-target agent with immense anti-inflammatory potential targeting key molecules of inflammation such as MPO, PGE2, and eight pro-inflammatory cytokine markers. Outcome of present study is to find promising anti-inflammatory bioactive agents from the cheapest Indian traditional medicinal plant sources useful for pharmaceutical industries.

Application of the herbal chemical marker ranking system (Herb MaRS) to the standardization of herbal raw materials: a case study

“…This lowers the infiltration macrophage to damaged tissues, hence reducing inflammation. [ 39 ]. It also chelates toxins such as heavy metal ions [ 40 ] Stimulates the production, and migration of keratinocytes and fibroblasts to injured tissues, by activating the PI3K-PKB/Akt and p38/ERK/MAPK pathways [ 41 ].…”

“…This lowers the infiltration macrophage to damaged tissues, hence reducing inflammation. [ 39 ]. It also chelates toxins such as heavy metal ions [ 40 ]…”

Ursolic acid inhibits NF-κB signaling and attenuates MMP-9/TIMP-1 in progressive osteoarthritis: a network pharmacology-based analysis

“… 62 Besides, COX-II responsible for the production of PGE2, NO and MMP-9 is also upregulated. 63 Moreover, the MMPs are a series of proteolytic enzymes (especially MMP-9 produced by monocytes) that downregulate the ECM synthesis and their biological activities are controlled by TIMP-1 (tissue inhibitor of metalloproteinase), where the imbalance in MMPs / TIMPs ratio is critical in the OA progression. 61 NF-κB is one of the inflammatory cytokine-induced transcription factors that regulate the expression of iNOS, COX-II, TNF-α, IL-6, MMPs and other cytokines.…”

Lupeol attenuated the NAFLD and PCOS-induced metabolic, oxidative, hormonal, histopathological, and molecular injuries in mice

“…Our findings indeed showed that LPL with a significant reduction in ROS/RNS generation and recovering the depleted glutathione level resulted in lower TNF-α and hepatic functional enzymes production, confirming its antioxidant and anti-inflammatory effects and also its medicinal use in the treatment of both disorders. The anti-inflammatory effect of LPL on carrageenan-induced acute inflammation in rodents and also on macrophage pro-inflammatory phenotype reduction in vitro model have been recently documented ( 36 37 ). There are also reports supporting the fact that mitochondria-targeted antioxidant, which is so-called Mito-Q10, with reduction of experimentally-induced PCOS injuries including elevated HOMA-IR and MDA levels and reduced glutathione content, was able to decline the mitochondria-mediated apoptotic cell death in the ovary ( 38 ).…”